You are here

lazertinib

J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug

Reuters

Thu, 09/28/23 - 12:08 pm

non-small cell lung cancer

Lazertinib and Tagrisso go head to head

EP Vantage

Fri, 03/24/23 - 10:01 am